Uncategorized

Melbourne-based packing group Pact (ASX:PGH) faced significant challenges in the 12 months leading up to June 30, resulting in financial losses and the omission of its final dividend. As there was no interim dividend, shareholders will experience a shortfall. However, Raphael Geminder, a wealthy Melbourne businessman and 49% owner of the company, won’t be impacted […]

The self-proclaimed “Number one Total TV Network,” Seven West Media (ASX:SWM), faced a considerable gap between its claim and reality as it reported declines in revenue and profits for the fiscal year ending on June 30. The notable aspect wasn’t Seven’s claimed top position, but rather its inability to translate that status into increased earnings

Property investors and manager Dexus (ASX:DXS) have issued a warning to investors, indicating that they can anticipate reduced returns in the fiscal year 2023-24. This caution follows an annual loss reported by the real estate firm for the period ending on June 30. The decline in values of CBD buildings has significantly impacted the company’s

16 Aug 2023 – A snapshot of the stocks on the move, featuring AML3D (ASX:AL3), Imugene (ASX:IMU) and Loyal Lithium (ASX:LLI).

AML3D (ASX:AL3) has received a $2M order from US Navy for submarine parts. In response, interim CEO Sean Ebert said: “AML3D’s focus is on the US defence, aviation and maritime sectors and the company is well positioned to access the many opportunities that will be created as a result of the AUKUS Alliance, in the

China’s shift towards deflation is causing concern in financial markets, yet some money managers suggest potential positive outcomes, as lower prices stemming from China’s role as a major global producer could lead to reduced costs worldwide. This deflationary trend might enable central banks to avoid further interest rate hikes, potentially pivoting towards easing to support

Investing in infrastructure can deliver downside protection, inflation protection and diversification. Tim Humphreys, Head of Global Listed Infrastructure at Ausbil Investment Management, discusses the asset class and opportunities in the short and medium term. Paul Sanger: Hi. I’m Paul Sanger from the Finance News Network, and today we’re interviewing Tim Humphreys, who is the Portfolio

16 Aug 2023 – Mark Leong – Executive Chairman – Osteopore (ASX:OSX) is a Singapore-headquartered corporation poised to be a leading medical device company in the region. It is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery use.

Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.

Tom Spurling – Executive Director – Nova Eye Medical (ASX:EYE) is introducing a comprehensive portfolio of novel glaucoma treatment options which span the entire disease process – enabling physicians to intervene earlier, and more often, in the treatment of glaucoma.